Muller-Myhsok; Bertram

Patent Applications and Registrations

Patent applications and USPTO patent grants for Muller-Myhsok; Bertram.The latest application filed is for "method for predicting a treatment response to a crhr1 antagonist and/or a v1b antagonist in a patient with depressive and/or anx".

Company Profile

0.6.10

Muller-Myhsok; Bertram - Munich DE
Muller-Myhsok; Bertram - Munchen DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method for predicting a treatment response to a CRHR1 antagonist and/or a V.sub.1B antagonist in a patient with depressive and/or anxiety symptoms Grant 10,837,062 - Holsboer , et al. November 17, 2	2020-11-17
Method For Predicting A Treatment Response To A Crhr1 Antagonist And/or A V1b Antagonist In A Patient With Depressive And/or Anx App 20190194752 - Holsboer; Florian ; et al.	2019-06-27
Method for predicting a treatment response to a CRHR1 antagonist and/or a V1B antagonist in a patient with depressive and/or anxiety symptoms Grant 10,190,168 - Holsboer , et al. Ja	2019-01-29
Polymorphisms in ABCB1 associated with a lack of clinical response to medicaments Grant 9,901,582 - Uhr , et al. February 27, 2	2018-02-27
Method For Predicting A Treatment Response To A Crhr1 Antagonist And/or A V1b Antagonist In A Patient With Depressive And/or Anxiety Symptoms App 20160153043 - HOLSBOER; Florian ; et al.	2016-06-02
New Polymorphisms In Abcb1 Associated With A Lack Of Clinical Response To Medicaments App 20160067262 - Uhr; Manfred ; et al.	2016-03-10
Genetic Predictors Of Response To Treatment With Crhr1 Antagonists App 20150278438 - Muller-Myhsok; Bertram ; et al.	2015-10-01
Polymorphisms in ABCB1 associated with a lack of clinical response to medicaments Grant 9,115,398 - Uhr , et al. August 25, 2	2015-08-25
Methods for Predicting an Antibody Response to Interferon Therapy in Multiple Sclerosis Patients App 20130252822 - Weber; Frank ; et al.	2013-09-26
Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis Grant 8,071,299 - Weber , et al. December 6, 2	2011-12-06
Use Of Gene Variants Of The Human Meis1, Btbd9, Map2k5, Lbxcor1, Ptprd Or A2bp1 Gene For Diagnostic And Therapeutic Approaches To Restless Legs Syndrome (rls) App 20100202972 - Winkelmann; Juliane ; et al.	2010-08-12
Polymorphisms In Abcb1 Associated With A Lack Of Clinical Response To Medicaments App 20100184742 - Uhr; Manfred ; et al.	2010-07-22
Methods For Predicting The Response Of Multiple Sclerosis Patients To Interferon Theraphy And Diagnosing Multiple Sclerosis App 20090186773 - Weber; Frank ; et al.	2009-07-23
Novel Target for Antiderpressant Therapy App 20070298027 - Binder; Elisabeth ; et al.	2007-12-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.